Reaction Details Report a problem with these data
Target
Alpha-2B adrenergic receptor
Ligand
BDBM50020192
Substrate
n/a
Ki
0.26±n/a nM
Comments
PDSP_1743
Citation
 O'Rourke, MF; Blaxall, HS; Iversen, LJ; Bylund, DB Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther 268:1362-7 (1994) [PubMed] 
Target
Name:
Alpha-2B adrenergic receptor
Synonyms:
ADA2B_DIDVI | ADRA2B | Alpha-2B adrenergic receptor | adrenergic Alpha2
Type:
Enzyme Catalytic Domain
Mol. Mass.:
41875.91
Organism:
OPOSSUM
Description:
adrenergic Alpha2 0 OPOSSUM::O77715
Residue:
382
Sequence:
AIAAVITFLILFTIFGNALVILAVLTSRSLRAPQNLFLVSLAAADILVATLIIPFSLANELLGYWYFRHTWCEVYLALDVLFCTSSIVHLCAISLDRYWSVSRALEYNSKRTPRRIKGIILTVWLIAAFISLPPLIYKGDKGKKPGGRPQCKLNEEAWYILSSSIGSFFAPCLIMILVYLRIYLIAKRRNRQGPHGKQAPGDGDTGPSALGGTSTISKLPPSILPAVGEANGHSKPPGEREGGEQMGDPTSPSTPPNQSSVGPEDGSQKQEEEEEEEEEEEEECGPPAPPTSSSLQGTPNFQPSQGSQVLATLRGQVLLARGPASLGLQPWRRRTQMNREKRFTFVLAVVIGVFVLCWFPFFFSYSLGAICPQHCKVPHGLF
  
Inhibitor
Name:
BDBM50020192
Synonyms:
8-(2,3-Dihydro-benzo[1,4]dioxin-2-ylmethyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one | CHEMBL300555 | Spiroxatrine
Type:
Small organic molecule
Emp. Form.:
C22H25N3O3
Mol. Mass.:
379.4522
SMILES:
O=C1NCN(c2ccccc2)C11CCN(CC2COc3ccccc3O2)CC1
Structure:
Search PDB for entries with ligand similarity: